Health Canada is informing health professionals and patients about a possible increased risk of certain heart-related events in men being treated for prostate cancer with a type of prescription drug known as a Gonadotropin-Releasing Hormone (GnRH) agonist.
http://www.hc-sc.gc.ca/ahc-asc/media...11_122-eng.php